To see complete information on smaller screens, select the blue plus (+) button beside the test name. . 1 Authorized settings include the following: 2 Authorization Documents include the Healthcare Provider (HCP) and Patient Fact Sheets and either the Manufacture Instructions/Package Insert (abbreviated to IFU) or the EUA Summary. Requires a Cue Cartridge Reader (sold separately). The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. In 1947, Salk accepted a professorship at the University of Pittsburgh School of . medical devices. Our Spectrum News app is the most convenient way to get the stories that matter to you. Everlywell was one of the first brands to release its at-home coronavirus test kit. For three weeks . This page also provides answers to FAQ's that pertain to testing types and supplies. Here is the commission's guidance as well as how to understand the tests: Check whether the COVID-19 test is FDA-approved . Here's a look at which at-home COVID tests the CDC says are approved by the FDA, and how long each of the kits are good for: BinaxNOW COVID-19 Ag Card Home Test, 15 months BinaxNOW. At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target,Telehealth Proctor Supervised (optional), Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Multiple Targets, Lateral Flow, Visual Read, Serial Screening, Single Target, Lateral Flow, Digital Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Serial Screening, Single Target, Chromatographic Digital Immunoassay, Instrument Read, Serial Screening, Single Target, Microfluidic Immunofluorescence Assay, Instrument Read, Serial Screening, Single Target, Lateral Flow, Visual Read, Single Target, Serial Screening, Lateral Flow, Fluorescence, Instrument Read, Multi-Analyte, Single Target, Magnetic Force-assisted Electrochemical Sandwich Immunoassay (MESIA), Single Target, Lateral flow immunoluminescent assay, instrument read, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Telehealth Proctor Supervised, Serial Screening, Single Target, Chemiluminescence Immunoassay, Instrument Read, Single Target, Lateral Flow, Visual Read, Multi-analyte, Single Target, Lateral Flow, Visual Read, Prescription Home Testing, Single Target, Chromatographic Digital Immunoassay, Instrument Read, Multi-analyte, Single Target, Bulk Acoustic Wave (BAW) Biosensor, Instrument Read, Serial Screening, Single Target, Lateral Flow, Visual Read, Serial Screening, Multiple Targets, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Lateral Flow, Visual Read, Serial Screening, Single Target, Lateral Flow, Fluorescence, Instrument Read, Single Target, Lateral Flow, Visual Read,Serial Screening, Single Target, Digital Lateral Flow, Fluorescence, Instrument Read, Single Target, Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Testing, Serial Screening, Single Target. Before sharing sensitive information, make sure you're on a federal government site. The types of samples include: Saliva samples are collected by spitting into a tube rather than using a nose or throat swab. The site is secure. Most authorized at-home OTC COVID-19 tests are antigen tests, and there. 2023, Charter Communications, all rights reserved. Since August 9, 2022, the standard regimen has also been authorized for people aged <18 years under . This infographic provides a visualization of data about the coronavirus (COVID-19) diagnostic tests authorized by the FDA. To see additional authorization documents, such as letters granting EUA amendments or revisions, and a list of other brand names authorized under a specific EUA, select the plus (+) button beside the "Date EUA Issued or Last Updated" for each EUA. Authorized at-home OTC tests are available without a prescription and are typically available online or at local stores. By taking these steps, the FDA and the test developer can quickly act in response to the potential risks identified and, when applicable, share the findings on SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests. The test is to be performed two times over three days (serial testing). The shelf-life is how long the test should work as expected and is measured from the date the test was manufactured. As new tests are authorized for use, they are added to these tables so that anyone can access up-to-date information on all authorized tests and collection kits. HCP, Recipients, IFU-ARCHITECT, IFU-Alinityi. The FDA communicated recommendations consistent with this revision in the August 11, 2022, Safety Communication: At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative. The FDA encourages developers to discuss any alternative technological approaches to validating their test with the FDA through CDRH-EUA-Templates@fda.hhs.gov. The site is secure. 263a, that meet requirements to perform moderate complexity tests. USGC Saliva Test Kit, hims/hers Saliva Test Kit, AZOVA At-Home COVID-19 Test Collection Kit, Wellness 4 Humanity SDNA-1000 Saliva Collection Kit, AZOVA P23 At-Home COVID-19 Test Collection Kit, binx health (powered by P23) At-home Saliva COVID-19 Test Collection Kit for the Group Setting, Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2 . databases. The most common sample types are: Swab samples use a swab (similar to a long Q-Tip) to collect a sample from the nose or throat. For information on tests that have been revoked see Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD). Qualitative detection of RNA from SARS-CoV-2 in individual human anterior nasal swabs or pooled samples containing aliquots of media from up to [3, 5, or 10, depending on the applicable appendix] individual human anterior nasal swab specimens that were collected by a healthcare provider (HCP) or self-collected under the supervision of an HCP from individuals, including individuals without symptoms or other reasons to suspect COVID-19 and placed in individual vials when tested at least once per week. The FDA has determined that establishing additional conditions is necessary to mitigate the potential risk of false negative results due to either decreased sensitivity or non-reactivity associated with SARS-CoV-2 viral mutations. For more information about how to reduce your risk of getting a false negative result on an at-home COVID-19 antigen test, read our FDA Safety Communication. When using a COVID-19 antigen diagnostic test, you should repeat testing following a negative result, whether you have symptoms or not, to reduce your risk of a false negative test result. 8/24/2021. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. The table below lists FDA-authorized at-home OTC COVID-19 diagnostic tests, and includes information on expiration dates, who can use the test, and other details that may help you decide what test is right for you. Results are usually available in 30 minutes or less. A molecular test detects the genetic material of SARS-CoV-2. This action is in response to available data about the performance of COVID-19 antigen tests showing that repeat testing after a negative COVID-19 antigen test result increases the chance of an accurate result in people with and without symptoms and could help prevent people from unknowingly spreading the SARS-CoV-2 virus to others. designed to detect more than one section of the proteins that make up SARS-CoV-2; more likely to continue to perform as labeled as new variants emerge. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Antigen EUA Revisions for Serial (Repeat) Testing, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), INDICAID COVID-19 Rapid Antigen At-Home Test, Letter Granting EUA Revision(s) (May 12, 2022), Letter Granting EUA Revision(s) (August 12, 2022), Letter Granting EUA Revision(s) (December 22, 2022), Letter Granting EUA Revision(s) (March 7, 2022), Letter Granting EUA Revision(s) (April 28, 2022), Letter Granting EUA Revision(s) (June 24, 2022), Letter Granting EUA Revision(s) (October 14, 2022), Letter Granting EUA Revision(s) (March 29, 2022), Letter Granting EUA Revision(s) (April 4, 2022), Letter Granting EUA Revision(s) (July 8, 2022), Letter Granting EUA Revision(s) (January 11, 2023), Letter Granting EUA Revision(s) (November 4, 2022), Letter Granting EUA Revision(s) (January 20, 2023), Letter Granting EUA Revision(s) (October 15, 2021), Letter Granting EUA Revision(s) (April 20, 2022), Letter Granting EUA Revision(s) (September 2, 2022), Letter Granting EUA Revision(s) (November 18, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Letter Granting EUA Amendment(s) (June 9, 2020), Letter Granting EUA Amendment(s) (July 17, 2020), Viral MutationRevision Letter - September 23, 2021, BD Veritor System for Rapid Detection of SARS-CoV-2, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (December 10, 2021), Letter Granting EUA Revision(s) (January 26, 2021), Letter Granting EUA Revision(s) (February 17, 2022), Letter Granting EUA Revision(s) (April 6, 2021), Letter Granting EUA Revision(s) (January 7, 2022), Letter Granting EUA Revision(s) (February 4, 2022), Letter Granting EUA Revision(s) (November 21, 2022), Letter Granting EUA Revision(s) (March 15, 2021), Letter Granting EUA Revisions(s) (July 16, 2021), Letter Granting EUA Revision(s) (December 2, 2021), Letter Granting EUA Revision(s) (January 17, 2023), VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack, Letter Granting EUA Revision(s) (November 16, 2021), BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, Letter Granting EUA Revision(s) (July 21, 2022), Letter Granting EUA Revision(s) (September 23, 2022), Letter Granting EUA Revision(s) (December 21, 2022), Letter Granting EUA Revision(s) (July 12 2021), Letter Granting EUA Revision(s) (February 16, 2022), Letter Granting EUA Revision(s) (October 25, 2022), Celltrion DiaTrust COVID-19 Ag Rapid Test, Letter Granting EUA Revision(s) (August 11, 2022), Letter Granting EUA Revision(s) (March 3, 2022), Letter Granting EUA Revision(s) (May 26, 2022), Letter Granting EUA Revision(s) (December 23, 2022), Sienna-Clarity COVID-19 Antigen Rapid Test Cassette, Letter Granting EUA Revision(s) (December 17, 2021), Letter Granting EUA Revision(s) (June 09, 2022), Letter Granting EUA Revision(s) (August 3, 2022), Letter Granting EUA Revision(s) (February 01, 2023), Letter Granting EUA Revision(s) (June 13, 2022), Letter Granting EUA Revision(s) (February 21, 2023), Letter Granting EUA Revision(s) (January 14, 2022), Letter Granting EUA Revision(s) (February 22, 2022), Letter Granting EUA Revision(s) (December 28, 2022), Letter Granting EUA Revision(s)(August 23, 2021), Letter Granting EUA Revision(s) (January 22, 2022), Letter Granting EUA Revisions(s) (June 7, 2022), Letter Granting EUA Revision(s) (August 29, 2022), Letter Granting EUA Revision(s) (September 28, 2022), Letter Granting EUA Revision(s) (Feburary 1, 2022, CLINITEST Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (June 23, 2022, Letter Granting EUA Revision(s) (October 12, 2022), Letter Granting EUA Revision(s) (December 27, 2022), MaximBio ClearDetect COVID-19 Antigen Home Test, Letter Granting EUA Revision(s) (March 30, 2022), Letter Granting EUA Revision(s) (July 22, 2022), Letter Granting EUA Revision(s) (December 16, 2022), Letter Granting EUA Revision(s) (January 09, 2023), Letter Granting EUA Revision(s) (May 4, 2022), Letter Granting EUA Revision(s) (December 2, 2022), Letter Graning EUA Revision(s) (February 24, 2023), ADVIA Centaur SARS-CoV-2 Antigen (CoV2Ag), Letter Granting EUA Revision(s) (August 19, 2022), Letter Granting EUA Revision(s) (October 18, 2022), Speedy Swab Rapid COVID-19 Antigen Self-Test, Letter Granting EUA Revision(s) (August 23, 2022). Cases, data, and surveillance to track and analyze COVID-19. UPDATE. In vitro diagnostic (IVD) devices are tests performed on samples taken from the human body, such as swabs of mucus from inside the nose or back of the throat, or blood taken from a vein or fingerstick. There are different types of COVID-19 tests diagnostic tests and antibody tests. In the table below, the "Expiration Date" column lists the shelf-life and where to find the expiration date for that test. Using the search box in the EUA tables, you can use keywords to search and filter the type of test or collection kit you are looking for. Appendix J - Sample Updated Fact Sheet for Health Care Providers, Appendix K - Sample Updated Fact Sheet for Patients, EUA Letter of Authorization - Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing, Appendix L - Fact Sheet for Health Care Providers (Template), Appendix M - Fact Sheet for Patients (Template), Laboratories Who Have Developed a Molecular-Based Test (LDTs) for Coronavirus Disease 2019 (COVID-19), Orig3n 2019 Novel Coronavirus (COVID-19) Test, Biocollections Worldwide SARS-Co-V-2 Assay, Avera Institute for Human Genetics SARS-CoV-2 Assay, Real-time RT-PCR, Home Collection, Saliva, Multiple Targets, RT, LAMP, Over the Counter (OTC) Home Testing, Saliva, Screening, Multiple Targets, Real-time RT-PCR, Home Collection, Multiple Targets, Screening, Pooling, Laboratory Corporation of America (Labcorp), Direct to Consumer (DTC), Real-time RT-PCR, Multi-analyte, Home Collection, Single Target, End-Point RT-PCR, Screening, Multiple Targets, Home Collection Kit, Screening, Single Target, Real-time RT-PCR, Home Collection, Screening, Multiple Targets, RT, LAMP, Lateral Flow Strips, Over the Counter (OTC) Home Testing, Serial Screening, Single Target, Real-time RT-PCR, Multi-analyte, Multiple Targets, Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute, Real-time RT-PCR, Multi-analyte, Home Collection, Multiple Targets, Yale School of Public Health, Department of Epidemiology of Microbial Diseases, Direct to Consumer (DTC), Real-time RT-PCR, Saliva, Home Collection, Screening, Pooling, Single Target, Direct to Consumer (DTC), Home Collection Kit, Saliva, Screening, Real-time RT-PCR, Home Collection, Multiple Targets, The Mount Sinai Hospital, Center for Clinical Laboratories, Real-time RT-PCR, Home Collection, Saliva, Screening, Multiple Targets, Centers for Disease Control and Prevention's (CDC), Real-time RT-PCR, Pooling, Multiple Targets, Wadsworth Center, New York State Department of Public Health, RT-PCR and electrochemical detection, Single Target, Real-time RT-PCR, Home Collection, Pooling, Multiple Targets, Real-time RT-PCR, Home Collection, Pooling, Screening, Multiple Targets, Real-time RT-PCR, Pooling, Screening, Multiple Targets, RT, Nested multiplex PCR, Pooling, Saliva, Multiple Targets, Real-time RT-PCR, Pooling, Screening, Saliva, Multiple Targets, RT, Isothermal amplification, Single Target, RT-PCR, Collection Kit, Saliva, Multiple Targets, RT-PCR, CoPrimer technology, Single Target, Real-time RT-digital PCR, Multiple Targets, Real-time RT-PCR, Screening, Multiple Targets, RT, Isothermal amplification, Multiple Targets, RT-PCR, Home Collection, Saliva, Single Target, Fast Track Diagnostics Luxembourg S..r.l. The expiration date is set at the end of the shelf-life. This test is usually conducted at the point-of-care or a sample is collected and . It quickly pivoted to a health professionals-only test and then rereleased its kit to the public after the. Sienna COVID-19 Antigen Rapid Test Cassette, Clarity COVID-19 Antigen Rapid Test Cassette, OVIOS COVID-19 Antigen Rapid Test Cassette, Spring Health COVID-19 Antigen Rapid Test, Salocor COVID-19 Antigen Rapid Test Cassette. Viral tests look for a current infection with SARS-CoV-2, the virus that causes COVID-19, by testing specimens from your nose or mouth. The FDA released an initial version of this infographicfor 2020. Be sure to check the At-Home OTC COVID-19 Diagnostic Tests website for information on expiration dates, who can use the test, and other details that may help you decide what test is right for you. Blood samples are only used to test for antibodies and not to diagnose COVID-19. This revision does not apply to EUAs for authorized IL-6 assays or standalone specimen collection devices and does not apply to EUAs that include substantially equivalent viral mutation conditions of authorization. The Food and Drug Administration has authorized the first over-the-counter at-home test that can detect and differentiate between a test result for flu and a test result for COVID-19. If you think you need a COVID-19 diagnostic test, you can find a community testing site in your state. The FDA said it has authorized over 400 COVID-19 tests and collection kits - 235 molecular, 88 antibody, and 34 antigen tests -- to help ensure the public has access to a wide variety of. They detect current infection and are sometimes also called "home tests," "at-home tests," or "over-the-counter (OTC) tests.". STATEN ISLAND, N.Y. -- The U.S. Food and Drug Administration (FDA) is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories. dba MicroGen DX, Columbia University Laboratory of Personalized Genomic Medicine, BioFire Respiratory Panel 2.1 (RP2.1) - On March 17, 2021, FDA granted the first marketing authorization using the De Novo review pathway for the. Samples for antibody tests are typically collected by a doctor or other medical professional by taking blood from a finger stick or your vein. People with symptoms that began within the last 4 days. W - Patient care settings operating under a CLIA Certificate of Waiver. Buy BinaxNOW Covid19 Antigen Self $19.88. These at-home OTC COVID-19 diagnostic tests are FDA authorized for self-testing at home (or in other locations). designed to detect two or more viral targets, or sections of the SARS-CoV-2 genome; more likely to continue to perform well when new variants emerge. IVDs can detect diseases or other conditions and can be used to monitor a person's overall health to help cure, treat, or prevent diseases. For additional performance information about EUA authorized serology/antibody tests, please see the EUA Authorized Serology Test Performance page. If potential impacts are identified, the EUA holder must communicate with the FDA and end users about the potential risk that presence of the mutations may have on test performance. Covering Phoenix, Mesa, Glendale, Scottsdale, Gilbert, the valley . . You can use the Test Type drop down box to select a Type of Test. Currently the FDA HAS NOT approved any at-home or self-test kits. Get hyperlocal forecasts, radar and weather alerts. The prevalence, and remaining unknowns, of the omicron variant have put people on edge and sent them out for testing in numbers that have caused the site at Barnett Park in Orange County to hit capacity hours before the it was scheduled to close two days in a row. For best results, the company says to wait at least 24 hours (but no more than 48 hours) in between tests. For most molecular COVID-19 diagnostic tests, you go to a testing site to have your sample collected and for others you can collect your own sample at home using a home collection kit and mail it to a laboratory for testing. Enter any combination of fields and select Search. Since the start of the pandemic, we authorized over 300 tests and collection kits, including: An official website of the United States government, : Tests with "single target" in the attribute column are: Tests with "multiple targets" in the attribute column are: To see additional authorization documents, such as letters granting EUA amendments or revisions, and a list of other brand names authorized under a specific EUA, select the plus (+) button beside the "Date EUA Issued or Last Updated" for each EUA. You can find information about each home or lab test that FDA has approved or cleared by searching FDAs Database of In Vitro Diagnostic (IVD) Tests. designed to detect only one antigen target, currently either a section of the spike protein or a section of the nucleocapsid protein; more susceptible to changes in performance due to viral mutations, meaning they are more likely to fail to detect new variants. . Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Shenzhen New Industries Biomedical Engineering Co., Ltd. Total Antibody, photonic ring immunoassay, Total Neutralizing Antibodies, Blocking ELISA, Semi-quantitative. As set forth in the September 23, 2021 letter, developers of authorized tests that are within the scope of the revision are now required to routinely monitor emerging viral mutations and their potential impact on the performance of the authorized SARS-CoV-2 test(s). The .gov means its official.Federal government websites often end in .gov or .mil. U.S. FDA 65%8. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. For additional information on reading and understanding your test results, see Understanding At-Home OTC COVID-19 Antigen Diagnostic Test Results. In this photo illustration, an at-home COVID-19 test by . The .gov means its official.Federal government websites often end in .gov or .mil. These include molecular tests,. Tests Used In Clinical Care, Recalls, Market Withdrawals and Safety Alerts, Safety Issue on Magellan Diagnostics LeadCare Testing Systems, enter a search term (for example the type of test, name, company, or other key word) in the blank space, review the listing of products that match your search term, select any products for additional information (including Decision Summaries). Below is a list of the 11 tests currently approved by the FDA for use at home: CareStart COVID-19 Antigen Home Test iHealth COVID-19 Antigen Rapid Test BD Veritor At-Home COVID-19. "COVID-19 is characterized by high levels of inflammatory markers, including C-reactive protein (CRP), and increased levels of inflammatory cytokines and chemokines. An antigen test, frequently used for rapid testing, detects viral proteins found in SARS-CoV-2. Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Recalls, Market Withdrawals and Safety Alerts, Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices, Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs, Remote or Wearable Patient Monitoring Devices EUAs, Ventilators and Ventilator Accessories EUAs, Emergency Use Authorizations for Medical Devices, In Vitro Diagnostics EUAs - Serology and Other Adaptive Immune Response Tests for SARS-CoV-2, Molecular Diagnostic Tests for SARS-CoV-2, Individual EUAs for Serology and Other AdaptiveImmune Response Tests for SARS-CoV-2, Umbrella EUA for Independently Validated Serology Tests for SARS-CoV-2, Historical Information about Device Emergency Use Authorizations: In Vitro Diagnostics (IVD), EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA (IgG), Letter Granting EUA Revision(s) (March 1, 2022), Letter Granting EUA Amendment(s) (May 9, 2020), Letter Granting EUA Amendment(s) (June 22, 2020), Letter Granting EUA Revision(s) (September 18, 2020), Letter Granting EUA Revision(s) (December 1, 2020), Viral Mutation Revision Letter (September 23, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, Letter Granting EUA Revision(s) (October 30, 2020), Letter Granting EUA Revision(s) (January 29, 2021), Letter Granting EUA Amendment(s) (July 22, 2020), Letter Granting EUA Revision(s) (October 19, 2020), Letter Granting EUA Revision(s) (October 7, 2021), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, Letter Granting EUA Revision(s) (May 20, 2020), Letter Granting EUA Revision(s) (October 23, 2020), Letter Granting EUA Amendment(s) (July 21, 2020), Letter Granting EUA Revision(s) (February 25, 2022), New York SARS-CoV Microsphere Immunoassay for Antibody Detection, Letter Granting EUA Amendment(s) (June 4, 2020), Letter Granting EUA Revision(s) (July 13, 2021), COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma), RightSign COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Amendment(s) (July 23, 2020), Letter Granting EUA Revision(s) (August 31, 2020), Dimension Vista SARS-CoV-2 Total antibody assay (COV2T), Letter Granting EUA Amendment(s) (August 7, 2020), Dimension EXL SARS-CoV-2 Total antibody assay (CV2T), Letter Granting EUA Revision(s) (April 21, 2022), Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit, Letter Granting EUA Amendment(s) (August 3, 2020), Letter Granting EUA Revision(s) (October 17, 2020), LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold), Letter Granting EUA Revision(s) (August 12, 2020), Letter Granting EUA Revision(s) (December 2, 2020), Letter Granting EUA Revision(s) (February 14, 2022), Assure COVID-19 IgG/IgM Rapid Test Device, Letter Granting EUA Revision(s) (January 31, 2022), Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette, Letter Granting EUA Revision(s) (July 12, 2021), Letter Granting EUA Revision(s) (March 9, 2022), BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test, Letter Granting EUA Revision(s) (November 6, 2020), Letter Granting EUA Revision(s) (October 31, 2020), Letter Granting EUA Revision(s) (March 19, 2021), BioCheck SARS-CoV-2 IgG and IgM Combo Test, Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test, Letter Granting EUA Revision(s) (November 2, 2021), Letter Granting EUA Revision(s) (November 19, 2021), BioCheck SARS-CoV-2 IgM Antibody Test Kit, BioCheck SARS-CoV-2 IgG Antibody Test Kit, Letter Granting EUA Revision(s) (November 10, 2020), Letter Granting EUA Revision(s) (November 5, 2021), Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit, OmniPATH COVID-19 Total Antibody ELISA Test, Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2, cPass SARS-CoV-2 Neutralization Antibody Detection Kit, Letter Granting EUA Revision(s) (February 1, 2022), COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit, Letter Granting EUA Revision(s) (May 4, 2021), Letter Granting EUA Revision(s) (February 9, 2022), Letter Granting EUA Revision(s) (August 24, 2022), Innovita 2019-nCoV Ab Test (Colloidal Gold), Letter Granting EUA Revision(s) (June 28, 2021), MidaSpot COVID-19 Antibody Combo Detection Kit, Letter Granting EUA Revision(s) (January 25, 2021), Letter Granting EUA Revision(s) (February 5, 2021), Letter Granting EUA Revision(s) (April 12, 2021), Letter Granting EUA Revision(s) (July 29, 2021), Letter Granting EUA Revision(s) (April 2, 2021), Letter Granting EUA Revision(s) (April 26, 2021), Letter Granting EUA Revision(s) (July 21, 2022), COVID-19 Self-Collected Antibody Test System, Letter Granting EUA Revision(s) (June 24, 2021), ZEUS ELISA SARS-CoV-2 Total Antibody Test System, Letter Granting EUA Revision(s) (February 28, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti- SARS-CoV-2 IgG Quantitative Calibrator, Letter Granting EUA Revisions(s) (September 8, 2021, Letter Granting EUA Revisions(s) (June 29, 2022), VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Reagent Pack used in combination with the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total N Antibody Calibrators, Letter Granting EUA Revision(s) (August 31, 2022), Diazyme SARS-CoV-2 Neutralizing Antibody CLIA Kit, SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests, IgG, Lateral Flow, Fingerstick Whole Blood, Wadsworth Center, New York State Department of Health, IgM and IgG Lateral Flow, Fingerstick Whole Blood, ThermoGenesis SARS-CoV-2 IgM/IgG Antibody Test Kit, IgM and IgG, Lateral Flow, Fingerstick Whole Blood.